Refining α-synuclein seed amplification assays to distinguish Parkinson’s disease from multiple system atrophy
Abstract Background Parkinson’s disease (PD) and multiple system atrophy (MSA) are two distinct α-synucleinopathies traditionally differentiated through clinical symptoms. Early diagnosis of MSA is problematic, and seed amplification assays (SAAs), such as real-time quaking-induced conversion (RT-Qu...
Saved in:
Main Authors: | James A. Wiseman, Clinton P. Turner, Richard L. M. Faull, Glenda M. Halliday, Birger Victor Dieriks |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | Translational Neurodegeneration |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40035-025-00469-6 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Positron emission tomography molecular imaging for pathological visualization in multiple system atrophy
by: La Dong, et al.
Published: (2025-03-01) -
β-synuclein in cerebrospinal fluid as a potential biomarker for distinguishing human prion diseases from Alzheimer’s and Parkinson’s disease
by: Bing Xu, et al.
Published: (2025-02-01) -
Preventing DNS misuse for Reflection/Amplification attacks with minimal computational overhead on the Internet
by: Rebeen Rebwar Hama Amin, et al.
Published: (2020-12-01) -
Preventing epileptogenesis by interaction between inositol isomers and proteins
by: Lia Tsverava, et al.
Published: (2025-02-01) -
Comparative reducing and carbohydrate enzyme inhibitory activities of the root, leaf, and seed of Picralima nitida
by: Erwin Osiele Onyekachukwu, et al.
Published: (2025-02-01)